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Abstract
Hepatitis B virus (HBV) is a diverse, partially double- stranded DNA virus, with 9 genotypes (A–I), and a putative 10th genotype 
(J), characterized thus far. Given the broadening interest in HBV sequencing, there is an increasing requirement for a consist-
ent, unified approach to HBV genotype and subgenotype classification. We set out to generate an updated resource of reference 
sequences using the diversity of all genomic- length HBV sequences available in public databases. We collated and aligned 
genomic- length HBV sequences from public databases and used maximum- likelihood phylogenetic analysis to identify geno-
type clusters. Within each genotype, we examined the phylogenetic support for currently defined subgenotypes, as well as iden-
tifying well- supported clades and deriving reference sequences for them. Based on the phylogenies generated, we present a 
comprehensive set of HBV reference sequences at the genotype and subgenotype level. All of the generated data, including the 
alignments, phylogenies and chosen reference sequences, are available online (https:// doi. org/ 10. 6084/ m9. figshare. 8851946) 
as a simple open- access resource.
InTRoduCTIon
Hepatitis B virus (HBV) is the prototype virus of the family 
Hepadnaviridae, an unusual family of partially double- 
stranded (ds) DNA viruses approximately 3.2 kb in length 
encoding four genes, including a reverse transcriptase, 
encoded in overlapping reading frames on a circular genome 
[1, 2]. To date, 9 genotypes of HBV have been characterized 
(A–I), along with a putative 10th genotype (J) [3]. The viruses 
display a relatively high amount of variation for a dsDNA 
virus [4], with the viral genotypes being further subdivided 
into upwards of 30 subgenotypes, many of which have distinct 
geographical and clinical associations [2].
At present, HBV genotyping is not being performed routinely 
in most clinical settings, as it has not been widely considered 
to be relevant to patient management. However, as more treat-
ment data become available and improvements are made in 
patient- stratified clinical care, guidelines may change to reflect 
different genotype- specific recommendations. This has been 
exemplified by the management of hepatitis C virus (HCV) 
infection [5], and a similar approach for HBV is starting to 
emerge, with recent European Association for the Study of 
the Liver (EASL) guidelines for HBV treatment suggesting 
different stopping points for treatment non- response in geno-
types A–D [6]. Evidence increasingly supports a role for HBV 
genotype in influencing disease progression, including risk 
of developing chronic infection, e- antigen seroconversion, 
transmission mode and the development of hepatocellular 
carcinoma [7, 8]. Studies often refer to ‘wild- type’ virus [8, 9], 
but wild- type for one genotype may not reflect consensus for 
other genotypes [10, 11]. Understanding the diverse range of 
HBV strains circulating globally, and their associations with 
disease, will allow us to move towards a more specific and 
precise approach to analysis.
A consistent approach to HBV subtyping is progressively 
more relevant, as interest in studying the associations 
between disease outcomes and viral sequence expands, 
and deep sequencing is used to investigate viral diversity in 
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increasingly larger cohorts. A progressive body of sequencing 
data is emerging, and this expansion of available data is 
likely to increase over time (Fig. S1, available in the online 
version of this article); however, the number of sequences 
covering the full genome lags a long way behind sequences 
for single genes or shorter fragments. To date, numerous 
subtyping misclassifications have been documented for HBV, 
predominantly driven by the use of partial genome sequences 
rather than full- length genomes [9, 10], the inappropriate 
classification of recombinant strains [11] and publications 
redesignating same subgenotype classifications to distinctly 
different strains [12, 13]. Whilst a number of HBV sequence 
and analysis resources already exist, including HBVdb [14], 
HBVRegDB [15], HBVDR [16] and geno2pheno (https:// 
hbv. geno2pheno. org/), each defines different sets of refer-
ence sequences, and frequently only at the genotype level. 
Criteria for the selection of reference sequences are often not 
provided with the resources, making it difficult to judge if 
the sequences are representative for the genotype. Several 
databases and resources offer subgenotyping from provided 
fasta sequences, but are not transparent about the sequences 
they use as references, making it unclear how many subgeno-
types they can identify. Despite proposed criteria for defining 
HBV genotypes and subgenotypes [3], currently there is no 
single resource where a concise set of well- evaluated reference 
sequences and their designations are readily available for use 
in an easily accessible format.
With this dataset, we have set out to provide a unified resource, 
taking a pragmatic approach to describing the phylogeny of 
HBV genotypes A–I using all available genotyped sequences 
from the HBVdb repository [14]. We removed highly similar 
sequences from downloaded alignments and performed 
maximum- likelihood phylogenetic analysis. We used the 
phylogeny of whole- genome sequences to identify well- 
supported clades and selected representative reference 
sequences for each identifiable subgenotype.
METHodS
definitions
We based our analysis on previously agreed definitions 
regarding the classification of HBV sequences on the basis of 
their nucleotide sequence diversity [3], as follows.
•	 Genotype: nucleotide divergence of >7.5 % has been pro-
posed as the threshold for the definition of distinct HBV 
genotypes [17].
•	 Subgenotype: Genotypes are further classified into sub-
genotypes, based on a divergence of 4–7.5 %, monophyletic 
clustering and strong bootstrap support for the clade [3].
In this study, we used strong bootstrap support (≥70) and 
monophyletic clustering to identify distinct clades and exam-
ined the pre- existing literature for the likely subgenotype 
designation. In instances when subgenotypes can be seen to 
split into distinct clades but genetic distance and poor boot-
strap support do not suggest a unique subgenotype, such as 
in the case of subgenotypes A1 and C2, we have referred to 
these as ‘A1 (1)’ and ‘A1 (2)’.
HBV genome numbering convention
As HBV is a circular virus, there is technically no ‘start’ or 
‘end’ to the genome. We have followed the convention in 
the field (and HBVdb) for this study, defining nucleotide 
(nt)1 at an EcoR1 restriction site in the Pol/Surface overlap 
(GAA/TTC, with nt1 starting at the first T) [2]. The EcoR1 
site is hypothetical in many HBV sequences, with GAA/CTC 
being more frequent in many genotypes.
Deletions and insertions are relatively common in HBV 
sequences [18, 19], meaning that a standardized approach to 
numbering is also required. We have followed convention and 
used the genotype A strain X02763 [20] as a numbering refer-
ence. Genotype A sequences are widely used as references as 
they are 3221 bp in length, with all other genotypes having 
a 6 bp deletion in the core gene (Fig. 1). Genotypes D, E, G 
and J have additional characteristic deletions in the pre- S1 
region (Fig. 1). All deletions should be described relative to 
genotype A, noting the nucleotide numbers that are missing. 
Insertions should also give the site of insertion relative to the 
genotype A reference, and use a decimal point to indicate the 
length of the insertion. For example, the characteristic 33 bp 
insertion seen in genotype G at nucleotide 1903 should be 
described as 1903.33.
Sources of sequence data
We downloaded all available genomic- length genotyped HBV 
sequences (n=7108) for genotypes A–H from HBVdb [14] on 31 
January 2019, and removed sequences indicated as recombinant 
by the database (n=767), giving a total of 6341 sequences. We 
used HBVdb as the database runs sequences downloaded from 
Genbank through a genotyping algorithm prior to inclusion and 
all listed sequences are annotated to ensure that they follow the 
HBV genome numbering [14], as outlined above.
We enhanced our dataset by excluding two sequences from 
the genotype G phylogeny, as they had been incorrectly 
genotyped with the HBVdb algorithm. Both sequences 
(FJ023674 and FR714503) were found to be partial geno-
type C recombinants. We also identified an additional 71 
sequences belonging to genotype I and to genotype C and D 
subgenotypes (under- represented in the HBVdb database) 
on GenBank and added these to our dataset, giving a total 
of 6412 sequences. Ancient HBV sequences, isolated from 
bodies hundreds of years old [21, 22], are present in these 
databases, and they were not excluded from this analysis, 
unless they grouped distantly from a known genotype.
Existing reference sequences
We included the genotype A strain X02763 [20] in the align-
ment with other reference sequences as this sequence (length 
3221 bp) is widely used as a numbering reference. Only 
genotype G has insertions relative to genotype A (Fig. 1). 
We suggest that the current NCBI HBV reference sequence, 
NC_003977.2 [23], a genotype D isolate, is less suitable as 
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a numbering reference, as genotype D strains have a 33 bp 
deletion in the pre- S1 region, making them the shortest 
length HBV genotype at 3182 bp (Fig. 1). Nonetheless, we 
also included NC_003977.2 in the reference alignment, as it 
is frequently used as a reference.
Phylogenetic analysis
We aligned all sequences using mafft [24] and calcu-
lated pairwise distances between all isolates. In order to 
reduce the possibility that multiple sequences from a single 
individual or closely related cluster could dominate the 
phylogeny, we kept only one sequence from each group 
of identical sequences, and used hierarchical clustering to 
group isolates based on their pairwise distance. We identi-
fied clusters of sequences that were within ≤1 % of each 
other, retaining a single sequence from each cluster for the 
analysis (retaining the sequence with the lowest proportion 
of ambiguous sites). After stripping out these closely related 
sequences, we generated a maximum- likelihood phyloge-
netic tree of the remaining 2839 sequences using RAxML 
[25], including 1000 bootstrap replicates (Fig. 2). We used 
this tree to manually delineate sequences belonging to 
each genotype and excluded any remaining recombinant 
sequences that had not been identified earlier in the process.
We aligned the sequences for each genotype separately 
and generated maximum- likelihood phylogenetic trees 
as previously described. We examined the phylogenetic 
trees and generated bootstrap values to define distinct 
clades containing ≥2 sequences with strong phylogenetic 
support (Figs  3–10). Phylogenetic trees were examined 
in both traditional and radial layouts to ensure that the 
subgenotypes and clades were being delineated accurately. 
We excluded genotype G from the phylogenetic analysis, 
as after removing highly similar sequences there were just 
three sequences remaining.
definition of new reference sequences
For each well- defined clade, we generated a consensus 
sequence and selected the closest clinical isolate to the 
consensus sequence as the reference strain for that clade. 
In instances where well- represented subgenotypes (with 
>100 sequences present in the analysis) clearly diverged 
into multiple distinct clades, we provided multiple reference 
sequences for the subgenotype, representing each clade. We 
applied a process of quality assurance to the selection of refer-
ence strains as follows.
Fig. 1. HBV genome lengths of each genotype. Standard genome lengths, and sites with deletions and insertions, are illustrated for 
genotypes A–J, along with a map of the HBV genome layout. Deletions and insertions are shown relative to genotype A, which is widely 
used as a numbering reference for HBV. Deletions are shown as white gaps and sites of insertions are indicated in black with triangles 
above them. All genotypes have a 6 bp deletion in the core (C), relative to genotype A (at nucleotide (nt)2354). Genotypes E and G have a 
3 bp deletion in the pre- S1 region (at nt2861) and genotypes D and J have a 33 bp deletion at the start of the pre- S1 region (at nt2854) 
[2]. Genotype G also has a 33 bp insertion in the core (at nt1903).
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•	 We verified that isolates selected as reference strains were 
associated with an associated publication indexed in Pub-
Med.
•	 We checked that reference strains were genuine clinical 
isolates (rather than in silico reconstructions such as con-
sensus sequences).
•	 We rejected isolates that had insertions or deletions rela-
tive to the majority of sequences in the clade.
•	 We avoided (where possible) sequences with many 
ambiguous sites.
•	 We avoided use of sequences containing known drug 
resistance mutations as reference strains. Thus in the situ-
ation in which a sequence containing an rtM204 substitu-
tion in the ‘YMDD’ motif (associated with escape from 
lamivudine therapy [26]) was initially selected as a refer-
ence sequence, and the resistance- associated mutation was 
not occurring in other sequences in the clade, we rejected 
this and selected the next closest sequence to consensus.
•	 We selected three subgenotype references with Hamming 
distances >50 relative to the consensus sequence for the 
subgenotype clade (subgenotypes C4, C11 and genotype C 
UA (2). More closely related sequences were present within 
the subgenotype clade but indels in the sequences and a 
lack of supportive publications meant that these sequences 
were not selected.
To define genotype reference sequences, we selected the 
reference sequence for the subgenotype that contributed 
the largest number of sequences to that genotype (Table 1, 
grey boxes). In cases where there were multiple clades for 
the subgenotype, we selected the sequence from the one of 
the largest clades of the most well- represented subgenotype 
as the reference. Where there was strong evidence to support 
specific subgenotypes from both the literature and the phylo-
genetic analysis, we included the subgenotype in the analysis. 
Where subgenotype designation was unclear, we used blast 
to compare the sequence(s) in the clade to other sequences in 
online databases to see if the subgenotype could be identified. 
We also examined trees to find the accession numbers of 
subgenotypes that did not have an easily identifiable clade in 
the analysis using isolates listed in GenBank. If they were not 
present, these subgenotypes were most likely removed during 
the pairwise analysis for being highly similar to sequences 
already in the analysis, suggesting further examination of 
Fig. 2. Genomic- length maximum- likelihood phylogeny of all genotype 
A–I HBV sequences included in analysis (n=2839) after removing 
highly similar sequences, indicating the number of sequences in each 
genotype analysed separately (Figs 3–10). Bootstrap support ≥70 after 
1000 replicates is given for the deepest branches on the tree. The scale 
bar indicates the estimated nucleotide substitutions per site. *, a strain 
known to be from a 14th century skeleton clustering distantly with 
genotype A, LT992441, was removed from the subsequent analysis. **, 
KU736915 was identified as a genotype D/E recombinant and removed 
from the subsequent analysis.
Fig. 3. Genomic- length maximum- likelihood phylogeny of HBV genotype 
A sequences (n=259). Well- defined clades have been highlighted with 
coloured dotted lines and reference sequences for each clade indicated 
(red dots). The proposed reference strain for the genotype, FJ692557, 
is highlighted with a blue dot. The subgenotype is given where it could 
be reliably identified. Bootstrap support for branches ≥70 after 1000 
replicates is indicated. The scale bar indicates the estimated nucleotide 
substitutions per site. Previous work has confirmed that there are 
at least five genotype A subgenotypes, although debate continues 
about whether A3, A4 and A5 should all be considered to be ‘quasi- 
subgenotype A3’ [9]. Few sequences for subgenotypes *A4 (KM606737) 
and **A6 (GQ331046) were retained in the study after pairwise analysis. 
The putative subgenotype A6 has previously been identified in three 
African- Belgian patients [37].
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their designation as a unique subgenotype may be warranted. 
In situations in which we could not ascertain which subgeno-
type a clade belongs to, despite examination of GenBank 
records and blast analysis of sequences, we described these 
as ‘unassigned clades’ (both in genotype C, UA (1) and UA 
(2), Fig. 5).
RESuLTS
Generation of a dataset of genomic-length HBV 
sequences
We downloaded a total of 7108 full- length HBV sequences from 
the hepatitis B virus database (HBVdb, https:// hbvdb. ibcp. fr/ 
HBVdb/) on 31 January 2019. Following clean- up of the dataset 
to remove identical sequences and recombinants (as described 
in detail in the Methods section) we were left with a total of 5972 
sequences. We aligned the sequences and calculated pairwise 
distances for hierarchical clustering to remove highly similar 
isolates (see the Methods section). At this stage we were left with 
2839 sequences on which we based our phylogenetic analysis 
(all sequences are shown in Fig. 2).
Classification of HBV genotypes and subgenotypes 
and designation of references
We selected appropriate reference sequences to represent 
each genotype and subgenotype groups; these sequences are 
shown in the context of the overall phylogeny highlighted 
in Figs 3–10 and listed in Table 1. In cases where we could 
identify multiple distinct clades within a single subgenotype 
(subgenotypes A1, B2, C2, D1; Figs 3–6), we selected a refer-
ence for each clade to ensure that the diversity within the 
subgenotype was represented. In genotypes A–D, the most 
well- represented subgenotypes contained ≥45 % of all the 
sequences within that genotype. Sequences were most evenly 
distributed between subgenotypes in genotype F, with the 
commonest subgenotype accounting for 33 % of sequences.
Ambiguities and inconsistencies in existing data
There are a number of poorly characterized and disputed 
subgenotypes in the literature, particularly within genotype 
C, making accurate identification of the subgenotypes chal-
lenging. Strong evidence to support a number of previously 
described clades was also difficult to obtain, and there were 
specific difficulties in the assessment of certain subgenotypes; 
D6, C7 and C9 were not easily distinguishable in this analysis. A 
search of GenBank indicated a single genomic- length sequence 
of subgenotypes A4 (KM606737), A6 (GQ331046) and D6 
(KF170740) in the database, and no evidence of genomic- length 
sequences for subgenotype C7 or C9 isolates. Both A4 and A6 
isolates clustered away from other sequences in the analysis, but 
few additional isolates of the subgenotypes were retained after 
the removal of highly similar sequences. In the case of subgeno-
type C7, previous publications on the phylogeny of genotype 
C used EU670263 as a C7 reference strain [27, 28]. However, 
in GenBank EU670263 is listed as subgenotype C6 [29] and 
clusters within our phylogenetic analysis with GU721029, which 
is also designated subgenotype C6. A single provisional isolate 
of subgenotype C9 exists (AP011108), having been proposed in 
2010 [27], but this designation is not present in the GenBank data 
associated with the sequence. Likewise, subgenotypes C13–16 
have been described [30], but we were unable to distinguish 
these as distinct subgenotypes in our analysis. The D6 isolate 
KF170740 was not retained in the sequences we selected for 
analysis, suggesting that it is closely related to another genotype 
D subgenotype.
Comparative phylogenies and pairwise distance of 
HBV genotypes
We aligned our newly defined genotype and subgenotype 
reference sequences and used them to generate a maximum- 
likelihood phylogenetic tree (Fig. 11). Pairwise distance anal-
ysis for the majority of genotypes (Fig. 12) revealed a bi- modal 
distribution of the distances, with one peak representing the 
relationship to sequences from the same (or closely related) 
clades (typically showing 1–3 % divergence) and the other 
peak being characteristic of distance to sequences in other 
clades from other subgenotypes (typically 3–8 % divergence). 
Genotype D differed from this distribution with a single peak 
where the majority of pairwise distances were between 2–4 %. 
Fig. 4. Genomic- length maximum- likelihood phylogeny of HBV 
genotype B sequences. Well- defined clades have been highlighted with 
coloured dotted lines and reference sequences for each clade indicated 
(red dots). The proposed reference strain for the genotype, GU815637, 
is highlighted with a blue dot. The subgenotype is given where it could 
be reliably identified. Bootstrap support for branches ≥70 after 1000 
replicates is indicated. The scale bar indicates the estimated nucleotide 
substitutions per site. An evaluation of the genotype B phylogeny 
reclassified a number of putative subgenotypes as quasi- B3, with 
debate continuing on whether or not this should also include B5 [53].
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This indicates that genotype D phylogeny does not contain 
long evolutionary branches separating clades from each 
other. Genotypes E, F, H and I contained smaller number of 
sequences, which can impact on the pairwise distance distri-
bution. In this group genotypes E, H and I showed a uni- modal 
distribution of the pairwise distances. The lowest pairwise 
divergence was observed in genotype H, where the majority of 
pairwise distances were <3 %. Genotype F demonstrated the 
greatest between- sequence diversity, where a high proportion 
of pairwise distances were >5 %, likely a reflection of the long 
evolutionary distance between subgenotypes. Genotype G 
only had three sequences after our initial filtering, which was 
too small for a meaningful pairwise distance analysis.
dISCuSSIon
Summary of this resource
We have collated genomic- length HBV reference sequences 
into a repository (available on Figshare, https:// doi. org/ 10. 
6084/ m9. figshare. 8851946), generating a resource that will 
help to underpin research. As clinical practice evolves to 
incorporate recommendations pertaining to HBV genotype, 
our dataset will also potentially become useful to support 
sequence- based insights for clinical practice. Many established 
databases are not currently designed for high- throughput 
work. Geno2pheno (https:// hbv. geno2pheno. org/), for 
example, only allows four sequences at a time to be analysed, 
making progress slow with many sequences. This is the first 
resource to validate nomenclature to subgenotype resolution 
(removing subgenotypes for which there are inadequate data) 
at the same time as designating a unique reference sequence 
for each genotype and subgenotype. The reference sequences 
are provided in an accessible format that is compatible with 
both low- and high- throughput sequence analysis, making it 
useful for a variety of applications.
Insights into diversity and geography
Genotype C has a particularly extensive phylogeny relative 
to the other genotypes. Genotype C is endemic in the Asia- 
Pacific region and is thought to be the oldest extant genotype 
[31]. The expansive diversity within this genotype is likely 
Fig. 5. Genomic- length maximum- likelihood phylogeny of HBV genotype C sequences. Well- defined clades have been highlighted with 
coloured dotted lines and reference sequences for each clade indicated (red dots). The proposed reference strain for the genotype, 
GQ377617, is highlighted with a blue dot. The subgenotype is given where it could be reliably identified. Bootstrap support for branches 
≥70 after 1000 replicates is indicated. The scale bar indicates the estimated nucleotide substitutions per site. We were unable to 
verify the subgenotype of two genotype C clades, and these have been designated unassigned clades 1 and 2 [unassigned_C (1) and 
unassigned_C (2), respectively].
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a consequence of its long evolutionary history in humans, 
although it should be noted that this genotype is also the 
best- represented genotype in the analysis, accounting 
for over 1/3 of all sequences in our dataset. Consider-
able diversity is also observed with genotypes B and D. 
Genotype D has a relatively broad geographical distribu-
tion, being found in regions including the Mediterranean, 
Fig. 6. Genomic- length maximum- likelihood phylogeny of HBV 
genotype D sequences. Well- defined clades have been highlighted with 
coloured dotted lines and reference sequences for each clade indicated 
(red dots). The proposed reference strain for the genotype, KC875277, 
is highlighted with a blue dot. The subgenotype is given where it could 
be reliably identified. Bootstrap support for branches ≥70 after 1000 
replicates is indicated. The scale bar indicates the estimated nucleotide 
substitutions per site. Previous work has indicated that the D3 and D6 
strains cluster together and should be classed as a single subgenotype 
[54].
Fig. 7. Genomic- length maximum- likelihood phylogeny of HBV 
genotype E sequences. Genotype E sequences do not diverge into 
distinct subgenotypes. Bootstrap support for branches ≥70 after 1000 
replicates is indicated. The scale bar indicates the estimated nucleotide 
substitutions per site. The proposed reference strain for the genotype, 
GQ161817, is highlighted with a blue dot.
Fig. 8. Genomic- length maximum- likelihood phylogeny of HBV genotype 
F sequences. Well- defined clades have been highlighted with coloured 
dotted lines and reference sequences for each clade indicated (red 
dots). The proposed reference strain for the genotype, HM585194, is 
highlighted with a blue dot. The subgenotype is given where it could be 
reliably identified. Bootstrap support ≥70 after 1000 replicates is given. 
The scale bar indicates the estimated nucleotide substitutions per site.
Fig. 9. Genomic- length maximum- likelihood phylogeny of HBV 
genotype H sequences. Genotype H sequences do not diverge into 
distinct subgenotypes. Bootstrap support ≥70 after 1000 replicates 
is given. The proposed reference strain for the genotype, FJ356715, 
is highlighted with a blue dot. The scale bar indicates the estimated 
nucleotide substitutions per site.
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North- eastern Europe, India, Oceania and parts of southern 
Africa [32]. It is possible that persistence of chronic HBV 
infection in these varied ethnic groups has contributed to 
the diversification of this genotype.
Genotype F has an atypical phylogeny compared to the other 
genotypes, comprising four subgenotypes separated by long 
evolutionary distances, but with little intra- subgenotype 
diversity. It is unclear if the unusual phylogeny is a result 
of the elevated substitution rate documented for genotype 
F [33] or if there is a paucity of sampling relative to the 
other genotypes. The genotype is distributed throughout 
Latin America and the Arctic Circle [34, 35], regions that 
are under- represented by clinical and research cohorts to 
date. Genotypes E, G and H, each of which has a single 
subgenotype, have relatively constrained phylogenies, 
showing low levels of genetic diversity in the currently 
sampled isolates. Genotype G has a particularly low evolu-
tionary rate, likely resulting from the 36 bp insertion in the 
core gene hampering viral replication [36]. The genotype is 
typically observed in co- infection with either HIV or HBV 
genotype A2 (36).
A HBV strain isolated from a 16th century skeleton 
(LT992440) clustered between subgenotypes in genotype 
A. The isolate falls (with long branch lengths) together with 
two sequences isolated from patients in Belgium, one of 
which has been proposed as the hypothetical subgenotype 
A6 (GQ331046), isolated in 2006 [37]. The clustering of 
these three sequences highlights the protracted association 
of HBV with human populations, and the marked lack of 
temporal population structure displayed by the viruses, 
frequently confounding phylogenetic attempts to under-
stand the evolutionary history of HBV [22, 38].
Limitations
Errors and inconsistencies in existing classification 
system
A number of previously described HBV subgenotypes 
were not identified using genomic- length HBV maximum- 
likelihood analysis in this study. A cause of these inconsist-
encies is the assigning of ‘provisional’ subgenotypes, based 
on a single isolate, as is the case with C7 and C9. Using 
the published literature to inform our analysis, we took an 
indication of strong bootstrap support, and a threshold of 
≥2 sequences to define and identify the subgenotype clades. 
For some subgenotypes, including A4 and A6, multiple 
isolates have been reported in the literature, but few isolates 
were retained in our analysis after removing highly similar 
sequences, suggesting divergence within the subgenotype is 
limited. Despite this approach, a number of clades grouped 
distinctly away from known subgenotypes but could not be 
categorically assigned to a subgenotype (thus we designated 
two ‘unidentified clades’ in genotype C).
We suggest that, in future, a minimum number of epidemio-
logically unlinked sequences and genomic coverage (e.g. ≥2 
genomic- length unlinked sequences) should be required to 
designate a new HBV subgenotype. Bias introduced into data-
bases from intra- host diversity studies, where multiple sequences 
are isolated from the same patient (such as clonal analysis), can 
confound such analyses, but should have been largely controlled 
for in this study by stripping the alignments of similar sequences.
The phylogenetic methods selected may affect the subgeno-
types classified, as there may be variability in bootstrap 
support between methods. Both neighbour- joining and 
parsimony methods are considered to be less accurate than 
maximum- likelihood approaches [39, 40], as used in this 
study. Recent work using Bayesian phylogenetic approaches 
to generate reference sequences for HBV was in agreement 
with our conclusions revising the number of subgenotypes 
downwards [41], illustrating the issue that several docu-
mented subgenotypes lack robust phylogenetic support. 
Future analysis to define HBV subgenotypes should therefore 
be based on maximum- likelihood methods and the bootstrap 
support should be indicated.
Bias in published data
There is considerable variation in the numbers of sequences 
available for each genotype, with genotypes B and C 
particularly well represented and genotypes E–I relatively 
neglected. Whilst these differences may reflect genuine 
variation in the contribution of different genotypes to the 
total global pool of infection – with B and C coming from 
high- prevalence, densely populated regions – significant 
undersampling of HBV sequences from other regions is 
likely (especially from low- income regions). Similar trends 
in isolate bias have been reported in the HCV field [42]. 
Consequently, the sequences available in publicly accessible 
databases are likely to under- represent the true extent of 
HBV diversity and, as more sequences are generated, refer-
ence sets will need to be reviewed.
Fig. 10. Genomic- length maximum- likelihood phylogeny of HBV 
genotype I sequences. Well- defined clades have been highlighted with 
coloured dotted lines and reference sequences for each clade indicated 
(red dots). The proposed reference strain for the genotype, AB562463, 
is highlighted with a blue dot. Bootstrap support for branches ≥70 after 
1000 replicates is indicated. The scale bar indicates the estimated 
nucleotide substitutions per site.
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Table 1. Proposed reference sequences for HBV genotypes, subgenotypes and clades
The number of sequences in each clade is given for each subgenotype and clade identified. Note that the total sum of the subgenotype sequence 
clusters may not correspond to the total number of genotype sequences, as a number of sequences did not group within a specific clade. Reference 
sequences for the genotypes are highlighted in grey boxes. In Figs 3–10, genotype references are marked with blue dots and subgenotype reference 
sequences are marked with red dots. Subgenotypes B5, C7, C9 and D6 are not included, as these sequences either did not cluster as monophyletic 
clades or were not retained in our analysis. Hamming distance indicates the number of nucleotide differences between the clade consensus and the 
chosen reference. The pairwise distance is the number of nucleotide differences between the clade consensus and the chosen reference normalized 
by length of the genome.
HBV 
genotype











A A1 (1) 50 KP168423 26 0.008 [55] 2012 Kenya
A1 (2) 87 FJ692557 21 0.007 [56] 2006 Haiti
A2 80 EU594385 5 0.002 [57] 2004 Estonia
A3 9 AM184126 29 0.009 [58] 2005 Gabon
A4 2 KM606737 n/a n/a [59] 2015 Cuba
A5 25 FJ692601 10 0.003 [60] 2006 Haiti
A6 2 GQ331046 n/a n/a [37] 2006 Belgium
B B1 47 D23679 23 0.007 [61] 1993 Japan
B2 (1) 131 JQ801514 15 0.005 [62] 2009 Thailand
B2 (2) 294 GU815637 10 0.003 [63] 2010 Taiwan, ROC
B3 106 AP011085 23 0.007 [64] 2001 Indonesia
B4 69 AB073835 35 0.011 [65] 2001 Japan
B6 36 AB287314 29 0.009 [66] 2006 Alaska
C C1† 240 DQ089781 29 0.009 [67] 2005 Hong Kong SAR
C2 (1) 261 KC774182 21 0.007 [68] 2012 PR China
C2 (2) 280 GQ377617 14 0.004 [69] 2007 PR China
C2 (3) 157 AP011098 10 0.003 [70] 2009 Indonesia
C4 21 KF873526 68 0.021 [71] 2011 Australia
C5 15 AP011099 41 0.013 [70] 2009 Indonesia
C6‡ 2 EU670263 28 0.009 [29] 2008 Philippines
C8 15 AP011107 42 0.013 [70] 2009 Indonesia
C10 21 KJ173333 33 0.010 [72] 2012 PR China
C11§ 28 AB554015 86 0.027 [28] 2010 Indonesia
UA (1) 31 KC774298 15 0.005 [68] 2012 PR China
UA (2) 16 DQ089802 55 0.018 [67] 2005 Hong Kong SAR
D D1 (1) 216 AB222711 11 0.003 [73] 2005 Uzbekistan
D1 (2) 106 KC875277 17 0.005 [74] 2013 India
D2 100 MF925358 21 0.007 [75] 2015 Bangladesh
D3 78 FJ692507 18 0.006 [60] 2006 Haiti
D4 15 FJ692533 17 0.008 [60] 2006 Haiti
D5 15 GQ205389 19 0.006 [76] 2008 India
D7 15 FJ904435 44 0.014 [77] 2006 Tunisia
Continued
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HBV 
genotype











E n/a 145 GQ161817 19 0.006 [78] 2006 Guinea
F F1 26 HM585194 13 0.004 [79] 2007 Chile
F2 13 DQ899143 26 0.008 [80] 2006 Venezuela
F3 19 MH051986 17 0.005 [81] 2011 Venezuela
F4 18 KJ843175 17 0.005 [82] 2012 Argentina
G n/a 3 AB056513 n/a n/a [83] 2001 USA
H n/a 11 FJ356715 36 0.011 [84] 2008 Argentina
I I1 5 AB562463 17 0.005 [85] 2007 Vietnam
I2 4 FJ023669 17 0.005 [86] 2008 Laos
J¶ n/a 1 AB486012 n/a n/a [86] 2006 Japan/Borneo
n/a, not applicable; (Subgenotype) this genotype does not diverge into multiple subtypes; (Hamming/Pairwise distance), too few sequences 
identified belonging to the genotype/subgenotype to generate consensus sequences for selection of closest biological isolate.
*Collection date of sample or year submitted to GenBank (if collection date not given).
†C1 is a large clade that also contains sequences labelled as subgenotype C3, with no clear separation between the two sets of sequences.
‡This sequence has been used previously as a subgenotype C7 reference in a number of publications [21, 22]. No other putative C7 sequences 
are proposed in the literature.
§C11, a large number of sequences were unpublished in this clade (>30 first closest seqs).
¶Genotype J remains putative, with a single isolate identified in a Japanese patient. The isolate shows considerable divergence from other known 
HBV strains and is thought to be a recombinant of genotype C and a gibbon HBV isolate.
Table 1. Continued
Fig. 11.  Genomic- length maximum- likelihood phylogenetic tree of 
HBV genotype, subgenotype and clade reference strains identified in 
Figs 3–10 and listed in Table 1 with accession numbers. The genotype 
is given in each case and the subgenotype or clade identification 
is given where possible. Bootstrap support for branches ≥70 after 
1000 replicates is indicated. The scale bar indicates the estimated 
nucleotide substitutions per site. In addition to the references identified 
in Figs  3–10, genotype A isolate X02763 and genotype D isolate 
NC_003977.2 have been included in the tree.
Fig. 12. Pairwise distance distribution for the genomic- length 
sequences of HBV genotypes A, B, C, D, E, F, H and I. Probability densities 
of pairwise distances for whole- genome sequences of HBV genotypes. 
Genotypes E, F, H and I are shown on a separate plot from genotypes A–D 
as they contained smaller number of sequences. Too few sequences 
were available after filtering for genotypes G and (putative) genotype 
J to be analysed.
281
McNaughton et al., Journal of General Virology 2020;101:271–283
Several previous studies publishing HBV reference 
sequence sets have generated consensus sequences from 
alignments of full- genome HBV sequences and submitted 
these new consensus sequences to GenBank [43, 44], which 
leads to the potential inference that these are sequences 
of biological origin. A number of genotype B, D and F 
sequences generated with the same approach have also been 
submitted to GenBank, but they are not supported by an 
associated publication, making it impossible to assess their 
provenance. The methods used to generate these sequences 
mean that, by definition, they occupy a basal position in the 
subgenotype clades after phylogenetic analysis and appear 
to be ideal reference sequences. However, these consensus 
sequences may differ from biologically derived sequences 
at key sites, and are therefore potentially misleading if used 
as reference sequences. Improved sequence metadata in 
the records of published sequences, clearly indicating the 
methods used to derive these sequences, would be informa-
tive for researchers.
Recombination and ‘quasi-subgenotypes’
Recombination is relatively common amongst HBV isolates 
[11, 45] and a number of established HBV subgenotypes 
have been shown to have a recombinant origin, particularly 
in genotypes A, C, D and the putative genotype J [45–47]. 
Recombination is likely to be even more prevalent within 
genotypes, however it is more difficult to detect between 
similar sequences. A number of sequences in our phylo-
genetic analysis were not easily classified, as they fall 
phylogenetically between two well- defined subgenotype 
clades. These sequences are possibly inter- subgenotype 
recombinants, combining genetic regions from two or 
more subgenotypes, making them challenging to classify 
in genomic- length phylogenies. Such recombinants are 
unlikely to have been filtered out by HBVdb [14], as the 
database only analyses sequences at the genotype level. 
Where possible, these sequences were excluded when 
defining the subgenotype clades to minimize their influence 
on the selection of reference sequences.
Previous work has indicated that some designated 
subgenotypes, including A3, A4, A5, C2 and B3, group 
as distinct, monophyletic clades in maximum- likelihood 
analysis, but that they do not meet the required genetic 
distance to be classified as separate subgenotypes [3, 9, 48]. 
It has been suggested these should instead be designated 
‘quasi- subgenotypes’ to reflect their divergent nature but 
underscore that they do not meet the technical definition 
of a subgenotype [9]. In our analysis, quasi- subgenotype 
A3 grouped into A3, A4 and A5 clades with strong boot-
strap support. It was not possible to separate subgenotypes 
C2 and quasi- B3 (encompasses B3 and B5) into distinct 
subgenotypes.
Conclusion
Sequencing is increasingly utilized in the clinical manage-
ment of HBV infection to inform on prognosis, treatment 
choice and drug resistance and to provide insight into 
complex cases [49, 50]. Whilst progress in applying new 
sequencing technologies to HBV has been slow to date, 
we are now entering an era of rapid change. A consistent, 
unified approach to classification will advance this field, 
improving the consistency with which sequence data are 
curated, archived and reported. Recent work sampling 
poorly accessed populations has uncovered numerous 
new HCV isolates [51, 52], and the diversity of sequences 
generated for HBV may expand in a similar way. The use 
of a robust and consistent classification system will also 
be important in screening new populations for potentially 
novel HBV isolates. The resource generated in this study is 
versatile and suitable for both low- and high- throughput 
sequence analysis. All of the generated data, including the 
alignments, phylogenies, consensus sequences and chosen 
reference sequences (Fig.  11), are available online as a 
simple open- access resource (https:// doi. org/ 10. 6084/ m9. 
figshare. 8851946). We have generated a new data resource 
for researchers and clinicians in the HBV field, providing a 
solid foundation for analysis, and a structure on which to 
build as more data emerge.
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